Objectives
Principal Investigators
 . Gerard Cangelosi
 . Ian Nicholas Crispe
 . Patrick Duffy
 . Michal Fried
 . Malcolm Gardner
 . Christoph Grundner
 . Helen Horton
 . Stefan Kappe
 . Peter Myler
 . Marilyn Parsons
 . David Sherman
 . Joseph Smith
 . Don Sodora
 . Leonidas Stamatatos
 . Ken Stuart
 . Ruobing Wang
 . Theodore White
Senior & Staff Scientists
Affiliate Scientists
Collaborations
Core Technologies
Malaria Clinical Trials Center

   
 

. Biography

. Publications

. Staff

. Links


Ken Stuart , Ph.D.

Member, Director and President
Seattle Biomedical Research Institute

Professor
Department of Global Health
University of Washington
Email: ken.stuart@sbri.org

Disease under study: Leishmaniasis, Chagas disease, African sleeping sickness

Mission
The Stuart lab studies complex single-celled organisms that cause a staggering amount of human and animal disease worldwide. The research is designed to develop understanding of fundamental molecular processes in these organisms in order to identify targets for new drugs and discover components of these parasites that can be developed into vaccines and diagnostic tools.

Research
The Stuart lab is focused on Trypanosomatid pathogens: Trypanosoma brucei, Trypanosoma cruzi, and Leishmania species. One major focus is on the process of, the molecular machinery for, and the physiological significance of RNA editing, and the potential for developing drugs directed at this process or its physiological role. 

Dr. Stuart determined the general mechanism of editing, identified many components of the editosome and the functions and interactions of many of these components. His lab is exploring editosome functional structure, steps in the editing process, and effects on parasite physiology upon disruption of editing. 

A second focus of the Stuart lab is functional genomics. He led the formation of international genome projects that sequenced and compared Trypanosome and Leishmania genomes in close collaboration with Peter Myler, Ph.D.  His current projects are building on these sequencing efforts and include a mitochondrial proteomic project.

Much of the support for Dr. Stuart’s research is provided by the National Institutes of Health (NIH).

 

HOME | CONTACT US | SITEMAP | DONATE | POLICY

©2009 Seattle Biomedical Research Institute. All rights reserved.

SBRI is a 501(c)3 not-for-profit organization. info@sbri.org